Biohub, member of IRDiRC’s Funders Constituent Committee, is offering three-year grants of $600,000 per organization to support patient-led research, strengthen organizational capacity, and accelerate therapeutic development.
Through the Rare As One Network, Biohub empowers patient-led organizations with the resources, scientific expertise, partnerships, and infrastructure they need to accelerate research and transform their disease communities.
Since launching in 2018, the Network has grown to include nearly 100 patient-led organizations. Together, these organizations are building collaborative research networks, developing patient registries, natural history studies, biobanks and disease models, establishing centers of excellence, and even supporting or sponsoring their own clinical trials.
Their work is transforming historically fragmented rare disease communities into coordinated research fields, bringing renewed momentum toward earlier diagnoses, effective treatments, and cures. The funding targets organizations working in three priority areas:
- Rare respiratory disorders
- Rare immune dysregulation disorders
- Rare sarcomas
Beyond financial support, Biohub will provide flexible funding, organizational and scientific training, capacity-building resources, and opportunities for peer learning and collaboration.
Through these investments, the Rare As One Network aims to equip patient-led organizations not only to shape research today, but also to build sustainable research ecosystems for the future.
More information: https://biohub.org/funding/rfa-rare-as-one-cycle-4/